Commercialization of a home-based LVEDP monitoring device (Hemolink)
Official title: Commercialization Readiness Pilot Program support for: HEMOLINK
Funded at Aventusoft, LLC · NIH-11315076 · Data updated 2026-11-12
A home-based tool would monitor a key heart function (LVEDP) to help people with heart disease manage their condition and potentially reduce hospital visits.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Aventusoft, LLC NIH-funded |
| Lab location | 1 site (Boca Raton, United States) |
| Project start | September 1, 2026 |
| Project end | August 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $500,000 |
| NIH project number | 1SB1HL184385-01 |
| Project ID | NIH-11315076 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults with cardiovascular conditions who require LVEDP monitoring or where LVEDP guidance could influence treatment decisions.
✕Less likely to help
Patients without access to home monitoring or those whose care does not involve LVEDP-guided decisions.
What this research studies
This project aims to take a non-invasive LVEDP estimation algorithm from early development to a commercially ready medical device that patients can use at home. It builds on prior work showing the algorithm can provide accurate, actionable heart data remotely. The plan is to finalize the development, obtain FDA clearance, and bring the device to market to support real-time clinical decisions and reduce hospitalizations for people with cardiovascular disease.
Why it matters
Potential benefit: If successful, patients could benefit from easier at-home monitoring and potentially fewer hospitalizations.
How similar studies have gone: Similar non-invasive, home-monitoring approaches have shown promise in improving remote management of cardiac conditions, with regulatory pathways actively pursued.
Where this research is happening
-
Aventusoft, LLC
Boca Raton, United States Active
Researchers
- Principal investigator: Kale, Kaustubh — Aventusoft, LLC
- Study coordinator: Kale, Kaustubh
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.